Target intelligence / Profile preview

Plasmolipin (PLLP)

Target
PLLP
Molecular classification
Other
01

Overview

Plasmolipin is a highly hydrophobic transmembrane protein encoded by the *PLLP* gene on chromosome 16, primarily localized in the myelin sheath and plasma membrane of nervous system cells[1][3]. It contains four transmembrane domains forming the MARVEL domain, facilitating membrane organization, vesicle trafficking, and myelin maintenance[1]. Plasmolipin is important in nervous system development, intracellular protein sorting, and is implicated in myelin assembly, Notch signaling, and the formation of lipid rafts[1][7]. Changes in plasmolipin expression have been associated with neurodegenerative diseases (such as Alzheimer’s and schizophrenia), certain cancers, and possibly metabolic disorders like type 2 diabetes[1]. While it shares some features with tetraspanins and other myelin proteins (e.g., MAL, PLP), it is not an ion channel or classical receptor and currently lacks direct therapeutic targeting by drugs[1][7].

Other names
Plasma membrane proteolipidPMLPTM4SF11Plasma membrane proteolipid (plasmolipin)Transmembrane 4 superfamily member 11 (plasmolipin)
02

Biological functions

Myelin assembly and maintenanceIntracellular transport, including vesicle trafficking and endocytosisLipid raft formation and membrane organizationRegulation of transcytosisInvolvement in Notch signaling
03

Disease associations

Neurodegenerative disease (associated with Alzheimer’s disease, schizophrenia)Cancer (altered expression may be linked to malignancy)Other (roles in type 2 diabetes, potential involvement as a viral entry protein)
04

Biomarkers

SchizophreniaPotential biomarker for neurodegeneration and certain malignancies

Beyond the preview

Go deeper on Plasmolipin (PLLP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmolipin (PLLP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call